Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Javier Zarranz-Ventura
Affiliation
Hospital Clinic of Barcelona, University of Barcelona
ORCID
Career Start Year
2008
Papers
92
H Index
20
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36627173
Artificial intelligence-based fluid quantification and associated visual outcomes in a real-world, multicentre neovascular age-related macular degeneration national database.
Br J Ophthalmol
2024
37528179
Correction: Save our Sight (SOS): a collective call-to-action for enhanced retinal care across health systems in high income countries.
Eye (Lond)
2024
37795556
Human selection bias drives the linear nature of the more ground truth effect in explainable deep learning optical coherence tomography image segmentation.
J Biophotonics
2024
35043004
Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO-Is there any difference? the VITDEX study.
Eye (Lond)
2023
37326222
Current status and practical considerations of artificial intelligence use in screening and diagnosing retinal diseases: Vision Academy retinal expert consensus.
Curr Opin Ophthalmol
2023
37326216
The impact of artificial intelligence on retinal disease management: Vision Academy retinal expert consensus.
Curr Opin Ophthalmol
2023
37344554
Validation of collaborative cyberspace virtual reality oculometry enhanced with near real-time spatial audio.
Sci Rep
2023
37280350
Save our Sight (SOS): a collective call-to-action for enhanced retinal care across health systems in high income countries.
Eye (Lond)
2023
37400599
Reasons for Delayed Anti-VEGF Treatment During COVID-19 Lockdown and Clinical Impact in Neovascular Age-Related Macular Degeneration.
Ophthalmol Ther
2023
36681366
Diabetic retinopathy in the pediatric population: Pathophysiology, screening, current and future treatments.
Pharmacol Res
2023
36675364
Predictive Factors and Management of Macular Edema after Retropupillary Iris-Claw Intraocular Lens Implantation in Aphakia: National Multicenter Audit-Report 2.
J Clin Med
2023
36729561
UNITED KINGDOM DATABASE STUDY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX) FOR MACULAR EDEMA RELATED TO RETINAL VEIN OCCLUSION.
Retina
2023
36371040
Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF: The Fight Retinal Blindness! Registry.
Ophthalmol Retina
2023
36331348
Preclinical ocular changes in systemic lupus erythematosus patients by optical coherence tomography.
Rheumatology (Oxford)
2023
33960115
Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry.
Acta Ophthalmol
2022
35567610
Validation of an autonomous artificial intelligence-based diagnostic system for holistic maculopathy screening in a routine occupational health checkup context.
Graefes Arch Clin Exp Ophthalmol
2022
35589075
Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry.
Ophthalmol Retina
2022
36578904
Radiomics-Based Assessment of OCT Angiography Images for Diabetic Retinopathy Diagnosis.
Ophthalmol Sci
2022
33686235
Paracentral acute middle maculopathy after uneventful ocular surgery with local anaesthetic blocks.
Eye (Lond)
2022
33712484
Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry.
Br J Ophthalmol
2022
35256644
Reference database of total retinal vessel surface area derived from volume-rendered optical coherence tomography angiography.
Sci Rep
2022
35307607
Characterization of Poor Visual Outcomes of Diabetic Macular Edema: The Fight Retinal Blindness! Project.
Ophthalmol Retina
2022
35179714
Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry.
Ophthalmol Ther
2022
34907129
INTERNATIONAL IMPACT OF THE COVID-19 PANDEMIC LOCKDOWN ON INTRAVITREAL THERAPY OUTCOMES: Fight Retinal Blindness Registry.
Retina
2022
35139688
Fluocinolone acetonide implant in diabetic macular edema: International experts' panel consensus guidelines and treatment algorithm.
Eur J Ophthalmol
2022
35106882
Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes.
Clin Exp Ophthalmol
2022
35292223
Reply to comment "Neglect what is near", related to the Editorial "Artificial Intelligence and Ophthalmology: Current status".
Arch Soc Esp Oftalmol (Engl Ed)
2022
34748794
Optical coherence tomography (OCT) angiolytics: a review of OCT angiography quantitative biomarkers.
Surv Ophthalmol
2022
34393212
IMPACT OF FLUID COMPARTMENTS ON FUNCTIONAL OUTCOMES FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Systematic Literature Review.
Retina
2022
32428922
Feasibility and Safety of a Coaxial Dual-Wavelength Optical Coherence Tomography Apparatus.
Ophthalmic Res
2021
33795837
Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations.
Eye (Lond)
2021
33547415
Unraveling the deep learning gearbox in optical coherence tomography image segmentation towards explainable artificial intelligence.
Commun Biol
2021
33710470
Systemic contribution of inflammatory mediators to the severity of diabetic and uveitic macular edema.
Graefes Arch Clin Exp Ophthalmol
2021
33675333
RETROPUPILLARY IRIS-CLAW INTRAOCULAR LENS AND PARS PLANA VITRECTOMY IN APHAKIA MANAGEMENT: A National Multicenter Audit.
Retina
2021
33801324
Retinal Microvascular Impairment in COVID-19 Bilateral Pneumonia Assessed by Optical Coherence Tomography Angiography.
Biomedicines
2021
35011940
Optical Coherence Tomography Angiography in Type 1 Diabetes Mellitus-Report 2: Diabetic Kidney Disease.
J Clin Med
2021
34573883
Optical Coherence Tomography Angiography in Type 1 Diabetes Mellitus. Report 4: Glycated Haemoglobin.
Diagnostics (Basel)
2021
34063291
Persistent Retinal Microvascular Impairment in COVID-19 Bilateral Pneumonia at 6-Months Follow-Up Assessed by Optical Coherence Tomography Angiography.
Biomedicines
2021
34340776
Artificial intelligence and ophthalmology: Current status.
Arch Soc Esp Oftalmol (Engl Ed)
2021
33433050
Recommendations for ophthalmologic practice during the easing of COVID-19 control measures.
Acta Ophthalmol
2021
33219442
Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age-related macular degeneration: real world data from the Fight Retinal Blindness registry.
Graefes Arch Clin Exp Ophthalmol
2021
32728935
Remote screening of retinal and optic disc diseases using handheld nonmydriatic cameras in programmed routine occupational health checkups onsite at work centers.
Graefes Arch Clin Exp Ophthalmol
2021
30994370
Long-Term Intravitreal Dexamethasone Implant Outcomes in Uveitis.
Ocul Immunol Inflamm
2020
32100249
A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study.
Pharmacoecon Open
2020
33062397
Optical Coherence Tomography Angiography in Type 1 Diabetes Mellitus. Report 1: Diabetic Retinopathy.
Transl Vis Sci Technol
2020
33235427
Comment on "Effectiveness of 190 µg Fluocinolone Acetonide versus 700 µg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis" [Response to Letter].
Clin Ophthalmol
2020
32606585
Effectiveness of 190 µg Fluocinolone Acetonide and 700 µg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis.
Clin Ophthalmol
2020
32678297
Validation of virtual reality orbitometry bridges digital and physical worlds.
Sci Rep
2020
31040132
Safety of 6000 intravitreal dexamethasone implants.
Br J Ophthalmol
2020
30608950
Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world.
PLoS One
2019
1 - 50 of 92
Column Actions
Search
Recommended Authors
Thais F Conti
Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic
Career Start Year
2018
Number of shared co-authors
3
Mariana Batista Gon??alves
Sao Paulo Federal University
Career Start Year
2018
Number of shared co-authors
1
Rita Laiginhas
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
Career Start Year
2015
Number of shared co-authors
2
John B Miller
Harvard Medical School
Career Start Year
2011
Number of shared co-authors
2
Christoph Mitsch
Medical University of Vienna
Career Start Year
2010
Number of shared co-authors
0
Andreas Pollreisz
Medical University of Vienna
Career Start Year
2007
Number of shared co-authors
0
Kelvin Yi Chong Teo
Singapore Eye Research Institute
Career Start Year
2007
Number of shared co-authors
12
Roy Schwartz
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year
2006
Number of shared co-authors
16
Gavin S W Tan
Singapore Eye Research Institute
Career Start Year
2006
Number of shared co-authors
12
Caio V Regatieri
Universidade Federal de Sao Paulo
Career Start Year
2006
Number of shared co-authors
1
Katherine E Talcott
Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic
Career Start Year
2005
Number of shared co-authors
3
Lisa C Olmos de Koo
University of Washington
Career Start Year
2005
Number of shared co-authors
4
Kasra A Rezaei
University of Washington
Career Start Year
2005
Number of shared co-authors
3
Yasha S Modi
New York University School of Medicine, New York University Langone Health
Career Start Year
2004
Number of shared co-authors
3
Stefan Sacu
Medical University of Vienna
Career Start Year
2002
Number of shared co-authors
0
Chui Ming Gemmy Cheung
Singapore Eye Research Institute
Career Start Year
2002
Number of shared co-authors
22
Jayashree Sahni
Novartis Pharma AG
Career Start Year
2001
Number of shared co-authors
9
Nadia K Waheed
Tufts University School of Medicine
Career Start Year
2001
Number of shared co-authors
18
Rishi P Singh
Cleveland Clinic Martin Hospitals, Cleveland Clinic Florida
Career Start Year
2000
Number of shared co-authors
9
Tunde Peto
Queen's University Belfast
Career Start Year
1999
Number of shared co-authors
23
Sobha Sivaprasad
NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital
Career Start Year
1999
Number of shared co-authors
33
Robin Hamilton
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year
1998
Number of shared co-authors
28
Glenn Yiu
University of California davis
Career Start Year
1998
Number of shared co-authors
0
Yoon Jeon Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year
1996
Number of shared co-authors
0
Ursula Schmidt-Erfurth
Medical University of Vienna
Career Start Year
1994
Number of shared co-authors
10
Allen C Ho
Wills Eye Hospital/Mid Atlantic Retina
Career Start Year
1992
Number of shared co-authors
4
Quan Dong Nguyen
Byers Eye Institute, Stanford University
Career Start Year
1990
Number of shared co-authors
12
Philip J Rosenfeld
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
Career Start Year
1981
Number of shared co-authors
15
Maureen G Maguire
Perelman School of Medicine, University of Pennsylvania
Career Start Year
1979
Number of shared co-authors
3
Neil M Bressler
Wilmer Eye Institute, Johns Hopkins University School of Medicine
Career Start Year
1979
Number of shared co-authors
10
row(s) 1 - 30 of 30
Collaborators
Adnan Tufail
Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers
21
Dawn A Sim
Institute of Ophthalmology, University College London
Co-authored papers
15
Pearse A Keane
Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers
15
Catherine Egan
Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers
14
Mark C Gillies
The University of Sydney Save Sight Institute
Co-authored papers
9
Vuong Nguyen
The University of Sydney Save Sight Institute
Co-authored papers
9
Daniel Barthelmes
University Hospital Zurich and University of Zurich
Co-authored papers
8
Peter M Maloca
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Co-authored papers
7
Hendrik P N Scholl
Institute of Molecular and Clinical Ophthalmology Basel
Co-authored papers
6
Hemal Mehta
The University of Sydney Save Sight Institute
Co-authored papers
6
Carlos Pavesio
Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers
6
Praveen J Patel
NIHR Moorfields Biomedical Research Centre
Co-authored papers
5
Aaron Lee
Harvard University, Moorfields Eye Hospital NHS Foundation Trust, St. John's Mercy Hospital, University of British Columbia, University of Washington, Washington University in Saint Louis
Co-authored papers
5
Mark Westcott
Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers
5
Pascal W Hasler
University Hospital Basel
Co-authored papers
5
Martin McKibbin
Leeds Teaching Hospitals NHS Trust
Co-authored papers
4
Usha Chakravarthy
Queen's University Belfast
Co-authored papers
4
Richard Gale
Hull York Medical School, University of York
Co-authored papers
4
Marcus Fruttiger
UCL Institute of Ophthalmology
Co-authored papers
4
Robert L Johnston
Gloucestershire Hospitals NHS Foundation Trust
Co-authored papers
4
Catey Bunce
Royal Marsden NHS Foundation Trust
Co-authored papers
4
Jay Chhablani
University of Pittsburgh
Co-authored papers
4
Salim Natha
Wigan and Leigh NHS Foundation Trust
Co-authored papers
3
Gerald Liew
Westmead Clinical School, University of Sydney
Co-authored papers
3
Toks Akerele
Hinchingbrooke Health Care NHS Trust
Co-authored papers
3
Louise Downey
Hull and East Yorkshire Hospital, Hull and East Yorkshire NHS Trust
Co-authored papers
2
Nora Denk
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Co-authored papers
2
Atul Varma
Mid Yorkshire Hospitals NHS Trust
Co-authored papers
2
Robyn H Guymer
Royal Victorian Eye and Ear Hospital, the University of Melbourne
Co-authored papers
2
Konstantinos Balaskas
University of Manchester
Co-authored papers
2
1 - 30